NECTID
Nectid, which was founded by Ram Sesha in 2008, to develop novel combination drugs and new chemical entities is under a new management led by pharma investors Dan Vasella and Rich Clark who acquired it 2014.
NECTID
Industry:
Biotechnology Chemical Pharmaceutical
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.nectid.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Nginx MonsterInsights Unified Layer
Similar Organizations
Biomedicina
Biomedicina is a pharmaceutical company.
Ceutical Labs
Ceutical Labs is a pharmaceutical company.
Medexus
Medexus is a Pharmaceutical Company.
Current Employees Featured
Official Site Inspections
http://www.nectid.com
- Host name: box2226.bluehost.com
- IP address: 50.87.253.245
- Location: Evanston United States
- Latitude: 42.0311
- Longitude: -87.6858
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60202
More informations about "Nectid"
Nectid - Crunchbase Company Profile & Funding
Nectid, which was founded by Ram Sesha in 2008, to develop novel combination drugs and new chemical entities is under a new management led by pharma investors Dan Vasella and Rich …See details»
NECTID
Our science-based Mix uses a unique synergistic method adopted by the liver to convert fat to super energy. It’s the only power packed MCT Mix to generate Ketone energy for your brain …See details»
Nectid - Overview, News & Competitors | ZoomInfo.com
Nectid. Manufacturing · New Jersey, United States · <25 Employees. Nectid is a privately held "science driven" pharmaceutical and nutritional technology company. Nectid, founded by …See details»
Nectid Inc - Company Profile and News - Bloomberg Markets
Nectid Inc operates a drug delivery and pharmaceutical research and development company. The Company discovers drugs and products for pain and depression.See details»
Nectid, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Nectid, Inc. with its drug pipeline, therapeutic area, technology platform, , Technology Platform:Small molecule drug, Drug:NFX-21(Nectid, Inc.), NCT-400, NRT-12, NRT-30, NRT …See details»
Nectid - Contacts, Employees, Board Members, Advisors & Alumni …
Nectid has 1 current employee profile, CEO and Chairman Daniel Vasella.See details»
Nectid (Pain Patent Portfolio) Company Profile 2024: Valuation ...
Information on acquisition, funding, investors, and executives for Nectid (Pain Patent Portfolio). Use the PitchBook Platform to explore the full profile.See details»
Nectid Announces Initiation Of Clinical Development Of Autism …
Aug 16, 2012 · Nectid, (www.nectid.com), is a Princeton based drug-discovery company that focuses on repurposing known drugs for Central Nervous System (CNS), developmental and …See details»
Nectid - Crunchbase
Nectid is a Pharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
Nectid, Inc. - CMOCRO
Nectid is a privately held drug discovery and nutritional technology development company. The focus is on discovering products and platforms that meet the unmet needs of healthcare …See details»
Grunenthal Group Acquires Pain Patent Portfolio From Nectid, Inc.
Mar 22, 2011 · The patent portfolio includes a number of novel chemical entities from Nectid's Pain Drug Discovery program and two key drug delivery platforms …See details»
John Lavedan - Sr Vice President - Nectid, Incorporated - LinkedIn
View John Lavedan’s profile on LinkedIn, the world’s largest professional community. John has 1 job listed on their profile. See the complete profile on LinkedIn and discover John’s …See details»
Nectid (Nectid inc) - Hugging Face
Org profile for Nectid inc on Hugging Face, the AI community building the future.See details»
Nectid Announces Initiation of Clinical Development of ... - BioSpace
Aug 16, 2012 · Nectid, (www.nectid.com), is a Princeton based drug-discovery company that focuses on repurposing known drugs for Central Nervous System (CNS), developmental and …See details»
NFX-21(Nectid, Inc.) - Drug Targets, Indications, Patents - Synapse
NFX-21 (Nectid, Inc.): a FXR modulators Drug, Initially developed by Nectid, Inc., Now, its global highest R&D status is Clinical, Mechanism: FXR modulators (Bile acid receptor FXR …See details»
Dipak Chattaraj | NECTID | United States of America - OMICS …
Chattaraj was formerly the chairman of Ranbaxy USA, a global generic pharmaceutical company. With over 35 years of global experience, Mr. Dipak Chattaraj has played a key role in Ranbaxy …See details»
Research programme: antidepressants - Nectid - AdisInsight
Nectid is developing therapeutics for the treatment of depressive disorders. One of the candidates is NRT 600, which is a melatonin receptor (MT1 and MT2)See details»
Nectid - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nectid is actively using 14 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and SPF.See details»
10 Principles of Effective Organizations - Harvard Business Review
Aug 8, 2022 · The author identifies 10 research-backed principles from the field of organization development to guide companies: 1) Encourage cooperation, 2) organize for change, 3) …See details»
Log in to your Okta org
If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, Okta.com, and much more. Learn …See details»